Erik Jorpes
Karolinska Institutet
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Erik Jorpes.
Journal of Pharmacy and Pharmacology | 1958
Erik Jorpes; Torbjörn Vrethammar; Bengt ÖHman; Birger Blombäck
Different techniques of assaying thrombic activity have been compared. The relative strength of three commercial thrombin preparations has been compared with that of an arbitrary standard. Heparinized plasma as used by Burstein and Guinand and TAME, toluene‐sulphonyl‐arginine methyl ester, as used by Sherry and Troll are both unsuitable as clotting substrates. Only purified fibrinogen can be used. Fibrinogen prepared according to M. and B. Blombäck proved to be suitable, giving only 3–7 per cent error in the thrombin determinations. It is suggested that the strength of the thrombin standard should be expressed by its capacity to split N‐terminal glutamic acid from fibrinogen with the appearance of N‐terminal glycine.
Biochemical Journal | 1971
V Mutt; Erik Jorpes
Acta Medica Scandinavica | 2009
Inga Marie Nilsson; Margareta Blombäck; Erik Jorpes; Birger Blombäck; Stig‐Arne Johansson
Acta Physiologica Scandinavica | 1966
Erik Jorpes; Viktor Mutt
Biochemical Journal | 1935
Erik Jorpes
Acta Chemica Scandinavica | 1961
Erik Jorpes; Viktor Mutt; Lars Gunnar Sillen
Biochemical Journal | 1931
Gunnar Ågren; Olof Wilander; Erik Jorpes
Acta Chemica Scandinavica | 1964
Erik Jorpes; Viktor Mutt; Kazimierz Toczko; D. R. Sparrow
Acta Haematologica | 1953
Erik Jorpes; Erik Odeblad; Harry Boström
Acta Medica Scandinavica | 2009
Erik Jorpes